Excellent educational experience at Swiss Oncology Summer School organized by Prof Curioni_Oncology_MD Universität Freiburg & ETH Zurich in the beautiful Gruyère. So exciting discussions with the new generations of researchers! Congrats Alessandra for an amazing workshop.Jarushka Naidoo Solange Peters

A heartfelt Thank you to Alexandra Curioni_Oncology_MD. And thanks to all students, whose energy, ideas and passion have been a true source of inspiration : the importance of staying courious! Jarushka Naidoo George Coukos Solange Peters ETH Zurich Faculty of Science and Medicine Fribourg

Ph III KN-789 Trial of Plt+Pemetrexed +/-Pembro in EGFR+ NSCLC post TKI Journal of Clinical Oncology: - 492pts - no PFS (5.6 v 5.5m) or OS (15.9 v 14.7m) benefit with ICI - ⬆️TRAEs (43.7% with ICI, 38.6% without) Not a beneficial strategy in this disease OncoAlert #LCSM ascopubs.org/doi/10.1200/JC…

🔥Ph III KN867 trial of SBRT+concurrent/adjuvant pembrolizumab stopped early due to higher AEs in IO arm, &lack of EFS&OS benefit Important negative data, that will inform optimum timing of IO, & definitive tx modality Lets see the data OncoAlert #LCSM merck.com/news/merck-pro…

‘Meet the Cancer Immunotherapy Experts’ at a special public event by Breakthrough Cancer Research 📅Aug 31 2024 📌Clayton Hotel Dublin ⏰4:30-7pm A great opportunity to chat to the greats in cancer immunotherapy, &some others 😉 #IrishLungCancerCommunity Beaumont RCSI Cancer Centre dublingazette.com/dublinlocalmat…

Fantastic event in Clayton Hotel tonight - facilitated by ⁦Breakthrough Cancer Research⁩ and Irish Society for Immunology - MC’ed expertly by ⁦Jonathan McCrea⁩ - delighted to hear ⁦The Nobel Prize⁩ winner James (Jim) P Allison and ⁦Jarushka Naidoo⁩

Dr Jarushka Naidoo #Cancer #Immunotherapy Guru is first up at #Irish Society 4 #immunology/Society for Immunotherapy of Cancer sponsored conference. Inspiration 4 her talk were words of wisdom from Prof. Jeffrey Weber NYU Langone Health Omid Hamid MD Paolo A. Ascierto #finishCancer #ISI2024 #ECI2024 #Dublin Aideen Ryan

Prof prof Joachim Aerts #mesothelioma & #pancreatic #immunotherapy expert Erasmus MC outlines his groups development of a novel mesothelioma vaccine. 5 #cancer cell lines provide lysate 2 pulse dendritic cells & inj Pts EFIS #ECI2024 #ISI2024 Aideen Ryan JL

A privilege to hear Nobel Prize Winner Jim Allison PhD speak today on how to take his seminal discovery of CTLA4 forward. Some thoughts: - move beyond PD1, CTLA4, LAG3 - tetrad ICI biomarkers - perioperative trials Society for Immunotherapy of Cancer Irish Immunology MD Anderson Cancer Center

Great discussion on T cell therapies by an impressive panel of speakers this morning at a fantastic meeting organised by Irish Immunology Society for Immunotherapy of Cancer Jarushka Naidoo Jim Allison PhD Padmanee (Pam) Sharma, MD, PhD Dr. Kristin Anderson, PhD Joachim Aerts #ECI2024 EFIS RCSI Beaumont RCSI Cancer Centre

Clinical+genetic factors assoc with Type I diabetes from ICIs JAMA Oncology: - Of 14328pts, incidence 0.45% - 3 phenotypes of T1DM exist, based on Ab & C-peptide(B): Ab+B-=earlier onset, ⬆️DKA - T1DGRS2 polygenic risk score= 4.4fold ⬆️risk OncoAlert #LCSM ja.ma/3MoT9xH

Thank you to all the organizers and speakers for a great day of pre-conference programming at #ECI2024! #ISI2024 Society for Immunotherapy of Cancer Irish Immunology EFIS RCSI Beaumont RCSI Cancer Centre Aideen Ryan Jennifer Guerriero, PhD JL Michael O'Dwyer

Very proud of Sze Ying (Karyn) a post-doc in my lab presenting our research on T-cell metabolism at #ECI2024 EFIS Irish Immunology Thanks to HealthResearchBoard Irish Cancer Society for sponsoring this work 🇮🇪🌼 Beaumont RCSI Cancer Centre RCSI RCSI Research and Innovation

Intracranial activity of Tarlatamab in 2L SCLC in Ph I DeLLphi-300 Trial Journal of Clinical Oncology: - 152pts, mfollow-up 12.1m - intracranial ORR 62.5% (all prior RT) - mOS 17.5m, ORR 25% Important data, now to make this easier to give to patients OncoAlert #LCSM ascopubs.org/doi/10.1200/JC…

At the #ESMO24, the ESMO Women for Oncology Committee will present new findings on female representation in leadership positions. Read the interview with Helena Linardou on the #ESMODailyReporter discussing the status of #GenderEquity in oncology ow.ly/cBPO50Tfeeb

Join us at #WCLC24 on Monday, September 9th, 7:30am, room 33ABC for the "Do You Know Your Targets" Quiz show where Dr. Natasha Leighl will go head to head against Dr. Ben Solomon! I'll play host and take a few crowd volunteers to play along for some prizes! IASLC Ben Solomon

T-2 days until IASLC #WCLC24! Gearing up for this joint ASCO IASLC session on early stage NSCLC - long term considerations 📅 Sat Sept 7 ⏰ 1pm 📌 30DE Join us! Jennifer C. King, PhD Enriqueta Felip #HidetoshiHayashi #RoslynJuergens #NicoleCulosReed #AnaBarac #EllenBarlow

Dear Colleagues, The OncoAlert 🚨Network Presents OUR Picks of TOP 🔟 #LungCancer 🫁Abstracts to be Presented at #ESMO24 This List Curated by: #OncoAlertAF Leads Hidehito HORINOUCHI 🇯🇵 Biagio Ricciuti, MD PhD 🇺🇸 Eric K. Singhi, MD 🇺🇸 Gil Morgan, MD 🇺🇸 With our Distinguished OncoAlert 🚨Faculty

Super proud of friend & colleague Imran Sulaiman on his prestigious European Research Council (ERC) Starter Grant, to investigate the use of lung microbiome metatransciptomics in early detection & diagnosis of NSCLC Imran Sulaiman #IrishLungCancerAlliance Beaumont RCSI Cancer Centre RCSI Research and Innovation #SOLACE #LCSM

T-1.5 days until IASLC #WCLC24 And here are your Social Media Ambassadors- the IASLC communications committee🔊 Follow these folks to track the best in thoracic onc in San Diego☀️ Matthew Smeltzer Stephen V Liu, MD Charu Aggarwal, MD, MPH, FASCO Aakash Desai, MD, MPH Dusty Joy Donaldson Narjust Florez, MD, FASCO RadOncResearch